Last news
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Notified -...

ThreatLocker® launches new solutions, further advances Zero Trust security resilience and adoption

ThreatLocker® launches new solutions, further advances Zero Trust security resilience and adoption

Notified -...

Philips publishes its Annual Report 2024

Philips publishes its Annual Report 2024

Notified -...

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Notified -...

Sport Business Global Golf Report: PGA Tour adapts to new challenges as women’s game grows

Sport Business Global Golf Report: PGA Tour adapts to new challenges as women’s game grows

Notified -...

Philips and Mass General Brigham announce collaboration to improve patient care with live AI-powered insights

Philips and Mass General Brigham announce collaboration to improve patient care with live AI-powered insights

Notified -...

Pacific Green Signs Agreement to Sell Its 250MW / 500MWh Limestone Coast North Battery Energy Park Development

Pacific Green Signs Agreement to Sell Its 250MW / 500MWh Limestone Coast North Battery Energy Park Development

Notified -...

WillScot Reports Fourth Quarter 2024 Results and Provides 2025 Outlook

WillScot Reports Fourth Quarter 2024 Results and Provides 2025 Outlook

Notified -...

1 ... 110 111 112 113 114 115 116 117 118 ... 831
menu
menu